Vasculitis syndromes: Tocilizumab-a new frontier for GCA therapy

Research output: Contribution to journalShort survey

1 Citation (Scopus)
Original languageEnglish (US)
Pages (from-to)700-701
Number of pages2
JournalNature Reviews Rheumatology
Volume13
Issue number12
DOIs
StatePublished - Nov 21 2017

Fingerprint

Vasculitis
Therapeutics
tocilizumab

ASJC Scopus subject areas

  • Rheumatology

Cite this

Vasculitis syndromes : Tocilizumab-a new frontier for GCA therapy. / Koster, Matthew; Warrington, Kenneth J.

In: Nature Reviews Rheumatology, Vol. 13, No. 12, 21.11.2017, p. 700-701.

Research output: Contribution to journalShort survey

@article{148e1cb5de154dce8eff1eb064a7f23b,
title = "Vasculitis syndromes: Tocilizumab-a new frontier for GCA therapy",
author = "Matthew Koster and Warrington, {Kenneth J}",
year = "2017",
month = "11",
day = "21",
doi = "10.1038/nrrheum.2017.150",
language = "English (US)",
volume = "13",
pages = "700--701",
journal = "Nature Reviews Rheumatology",
issn = "1759-4790",
publisher = "Nature Publishing Group",
number = "12",

}

TY - JOUR

T1 - Vasculitis syndromes

T2 - Tocilizumab-a new frontier for GCA therapy

AU - Koster, Matthew

AU - Warrington, Kenneth J

PY - 2017/11/21

Y1 - 2017/11/21

UR - http://www.scopus.com/inward/record.url?scp=85034756735&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85034756735&partnerID=8YFLogxK

U2 - 10.1038/nrrheum.2017.150

DO - 10.1038/nrrheum.2017.150

M3 - Short survey

C2 - 28878334

AN - SCOPUS:85034756735

VL - 13

SP - 700

EP - 701

JO - Nature Reviews Rheumatology

JF - Nature Reviews Rheumatology

SN - 1759-4790

IS - 12

ER -